🇺🇸 FDA
Patent

US 9061027

Enhanced delivery of drug compositions to treat life threatening infections

granted A61KA61K31/496A61K9/0073

Quick answer

US patent 9061027 (Enhanced delivery of drug compositions to treat life threatening infections) held by The Board of Regents of the University of Texas System expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/496, A61K9/0073, A61K9/008, A61K9/19